Valuation: QuidelOrtho Corporation

Market Cap 1.14B 1B 929M 855M 1.6B 110B 1.63B 11.11B 4.33B 53.73B 4.27B 4.18B 186B P/E 2026 *
-10.4x
P/E 2027 * -104x
Enterprise Value 3.51B 3.08B 2.86B 2.63B 4.94B 340B 5.03B 34.26B 13.36B 166B 13.16B 12.88B 575B EV / Sales 2026 *
1.29x
EV / Sales 2027 * 1.23x
Free-Float
99.1%
Yield 2026 *
-
Yield 2027 * -
1 day-0.60%
1 week-9.10%
Current month-5.34%
1 month+38.92%
3 months+47.51%
6 months-40.98%
Current year-41.95%
1 week 15.54
Extreme 15.545
18.19
1 month 11.84
Extreme 11.84
19.8
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
89.11
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 2024-05-05
Director of Finance/CFO 48 2026-07-05
Chief Operating Officer 57 2024-11-14
Director TitleAgeSince
Chairman 72 2022-12-10
Director/Board Member 71 2021-12-31
Director/Board Member 82 1992-12-31
Date Insider Type Main position Quantity % Market Cap.
7/15/26 Free

Chief Financial Officer

356,555 0.5251%
7/6/26 Other

Chief Financial Officer

0 0%
7/1/26 Fiscal year

EVP Global Port. Mgmt & Mkting

13,690 0.0202%
Change 5-day change 1-year change 3-year change Capi.($)
-0.60%-9.10%-37.67%-81.22% 1.14B
+0.23%-10.35%+15.85%-36.63% 15.8B
+9.95%+3.06%+10.99%+115.26% 1.63B
-4.66%-5.73%-37.45%+10.63% 1.01B
+0.57%-4.41%-30.13%-53.93% 627M
+2.48%-7.99%-46.66%-56.93% 505M
+0.56%-0.37%+39.40%-53.69% 449M
-2.94%-6.16%-55.92%-62.88% 372M
-2.25%+2.66%-19.47%-39.30% 350M
+2.43%-5.66%+53.53% - 317M
Average +0.48%-1.34%-10.75%-28.74% 2.22B
Weighted average by Cap. +0.64%-7.14%+6.86%-27.28%

Financials

2026 *2027 *
Net sales 2.71B 2.38B 2.21B 2.04B 3.82B 262B 3.89B 26.48B 10.33B 128B 10.17B 9.95B 444B 2.8B 2.46B 2.29B 2.1B 3.94B 271B 4.02B 27.35B 10.67B 132B 10.51B 10.28B 459B
Net income -156M -137M -127M -117M -220M -15.09B -224M -1.52B -594M -7.36B -585M -572M -25.54B -81.93M -72.06M -66.94M -61.57M -115M -7.93B -118M -801M -312M -3.87B -308M -301M -13.43B
Net Debt 2.37B 2.08B 1.94B 1.78B 3.34B 229B 3.4B 23.15B 9.03B 112B 8.89B 8.7B 388B 2.3B 2.02B 1.88B 1.73B 3.24B 223B 3.3B 22.46B 8.76B 109B 8.63B 8.44B 377B
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
26-07-23 US$16.58 -0.60% 805,984
26-07-22 US$16.68 +1.52% 1,257,035
26-07-21 US$16.43 -0.90% 1,274,873
26-07-20 US$16.58 -4.60% 728,919
26-07-17 US$17.38 -4.71% 1,106,190
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
16.68USD
Average target price
20.50USD
Spread / Average Target
+22.90%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QDEL Stock